Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Goldenberg

Showing results (711-720 of 968) with videos related to

Pageof 97
Sort By:
Cancer|February 4, 2010
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapyLudovic Ferrer, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 29, 2020
Efficacy and safety of decontamination for N95 respirator reuse: a systematic literature search and narrative synthesisBenjamin E Steinberg, Kazuyoshi Aoyama, Mark McVey, et al.
JAMA Dermatology|August 19, 2014
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgarisChristoph T Ellebrecht, Eun J Choi, David M Allman, et al.
Haematologica|August 24, 2014
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaThomas E Witzig, Michael B Tomblyn, Jamal G Misleh, et al.
Nuclear Medicine Communications|February 9, 1999
In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragmentsR W Kinne, K Schemer, T Behr, et al.
Clinical Therapeutics|December 23, 2016
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and DiagnosisRonald M Goldenberg, Lori D Berard, Alice Y Y Cheng, et al.
CMAJ Open|October 13, 2016
Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort studyNeil M Goldenberg, Benjamin E Steinberg, James T Rutka, et al.
Cancer Research|February 1, 1990
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibodyJ A Siegel, D A Pawlyk, R E Lee, et al.
Current Medical Research and Opinion|January 28, 2025
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithmsRonald M Goldenberg, Jeremy D Gilbert, Robyn L Houlden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
CD74: a new candidate target for the immunotherapy of B-cell neoplasmsRhona Stein, M Jules Mattes, Thomas M Cardillo, et al.
Pageof 97

Showing results (711-720 of 968) with videos related to

Sort By:
Pageof 97
Cancer|February 4, 2010
Three methods assessing red marrow dosimetry in lymphoma patients treated with radioimmunotherapyLudovic Ferrer, Françoise Kraeber-Bodéré, Caroline Bodet-Milin, et al.
Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|July 29, 2020
Efficacy and safety of decontamination for N95 respirator reuse: a systematic literature search and narrative synthesisBenjamin E Steinberg, Kazuyoshi Aoyama, Mark McVey, et al.
JAMA Dermatology|August 19, 2014
Subcutaneous veltuzumab, a humanized anti-CD20 antibody, in the treatment of refractory pemphigus vulgarisChristoph T Ellebrecht, Eun J Choi, David M Allman, et al.
Haematologica|August 24, 2014
Anti-CD22 90Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphomaThomas E Witzig, Michael B Tomblyn, Jamal G Misleh, et al.
Nuclear Medicine Communications|February 9, 1999
In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragmentsR W Kinne, K Schemer, T Behr, et al.
Clinical Therapeutics|December 23, 2016
SGLT2 Inhibitor-associated Diabetic Ketoacidosis: Clinical Review and Recommendations for Prevention and DiagnosisRonald M Goldenberg, Lori D Berard, Alice Y Y Cheng, et al.
CMAJ Open|October 13, 2016
Research projects in the Surgeon-Scientist and Clinician-Investigator programs at the University of Toronto (1987-2016): a cohort studyNeil M Goldenberg, Benjamin E Steinberg, James T Rutka, et al.
Cancer Research|February 1, 1990
Tumor, red marrow, and organ dosimetry for 131I-labeled anti-carcinoembryonic antigen monoclonal antibodyJ A Siegel, D A Pawlyk, R E Lee, et al.
Current Medical Research and Opinion|January 28, 2025
Perioperative and periprocedural management of GLP-1 receptor-based agonists and SGLT2 inhibitors: narrative review and the STOP-GAP and STOP DKA-2 algorithmsRonald M Goldenberg, Jeremy D Gilbert, Robyn L Houlden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
CD74: a new candidate target for the immunotherapy of B-cell neoplasmsRhona Stein, M Jules Mattes, Thomas M Cardillo, et al.
Pageof 97